GSK3B and hepatocellular carcinoma: Unexpectedly, CHIR-99021 treatment of Huh7 (HCC cells) (Fig. 4A) and LX2 cells (HSCs) (Fig. 4B) did not alter phosphorylation of GSK-3β at Ser 9 or Tyr 216, unlike the effect of SB-216763.